SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-105074
Filing Date
2021-08-13
Accepted
2021-08-13 16:06:26
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acxp-20210630x10q.htm   iXBRL 10-Q 1283226
2 EXHIBIT 31.1 acxp-20210630xex31d1.htm EX-31.1 15190
3 EXHIBIT 31.2 acxp-20210630xex31d2.htm EX-31.2 15214
4 EXHIBIT 32.1 acxp-20210630xex32d1.htm EX-32.1 6450
5 EXHIBIT 32.2 acxp-20210630xex32d2.htm EX-32.2 6471
  Complete submission text file 0001104659-21-105074.txt   4088019

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acxp-20210630.xsd EX-101.SCH 36631
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acxp-20210630_cal.xml EX-101.CAL 20237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acxp-20210630_def.xml EX-101.DEF 128446
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acxp-20210630_lab.xml EX-101.LAB 277543
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acxp-20210630_pre.xml EX-101.PRE 239368
11 EXTRACTED XBRL INSTANCE DOCUMENT acxp-20210630x10q_htm.xml XML 413939
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 211172106
SIC: 2834 Pharmaceutical Preparations